Rareshare

just dianosed with this cancer....are you still checking this sight? I hope so cause I really wanted someone to chat with that is going thru what I am. Please respond if your still here.

Posted by ZEESMAN
8 Jul 2008, 06:21 PM

My first symptoms were in June 2006, and they appeared as a heavy itch and rash on my back. I was treated for 6 months,and after the 3rd biopsy, they found the Mycosis. I had phototherapy for a year, and in Dec./07,I was started on interferon shots, three times a week. They didn't feel that was working, and this April I stopped phototherapy, and strarted 6 weeks of radiation. That seemed to have helped, as the itch is less severe now, as well as the rash.

View Full Thread

Community Resources

Title	Description	Date	Link
Cutaneous Lymphoma Foundation	The website of the Cutaneous Lymphoma Foundation.	03/20/2017
Lymphoma Rashes: Symptoms and Treatments	Advice from mylymphomateam.com.	10/02/2020

Clinical Trials

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

Complete the screening form.
Review the informed consent.
Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.